<?xml version="1.0" encoding="UTF-8"?>
<p class="p">EFEN markedly improved the absorption and availability of EA, resulting in a higher absorptive constant (8.38 times) and higher bioavailability (362.21% increase) (
 <xref ref-type="fig" rid="F0006" class="xref">Figure 6(a,b)</xref>). NFEN was retained in the tumor area when injected subcutaneously into the tissue near the tumor (
 <xref ref-type="fig" rid="F0006" class="xref">Figure 6(c)</xref>).
</p>
